Back to SO Squarepoint Ops LLC
CTXR3 quarters
Position history for SOSquarepoint Ops LLC's holdings in CITIUS PHARMACEUTICALS INC
No. Squarepoint Ops exited its CTXR (Citius Pharmaceuticals) position in Q2 2025. Its Q1 2025 13F listed 60,983 shares worth $90,865. Squarepoint Ops already held CTXR in its Q4 2024 13F, the earliest on record, and held it in 2 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$198,672
Total Shares Change
-49,668
Quarter-by-Quarter History
Other major holders of CTXR: VANGUARD GROUP INC, UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc.